11c-L-Selegiline-D2 Uses, Dosage, Side Effects and more
11c-L-Selegiline-D2 is under investigation in clinical trial NCT01701089 (A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers).
| Attribute | Details |
|---|---|
| Trade Name | 11c-L-Selegiline-D2 |
| Generic | L-deprenyl-D2 C-11 |
| L-deprenyl-D2 C-11 Other Names | (11C)L-deprenyl-D2, 11c-L-Selegiline-D2 |
| Type | |
| Formula | C13H17N |
| Weight | Average: 188.299 Monoisotopic: 188.160086861 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
